Physician

Aalok Devendra Shah, M.D.

According to 2025 Medicare claims, Aalok Shah, M.D. (NPI: 1568429678) practices pulmonary disease in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from San Bernardino, CA. This provider's primary affiliated billing organization is DARIN RENTZ DO PC (NPI: 1689321747; TIN: 880658232) and primary practice location at 92373-4850. Shah is affiliated with the Optum California ACO (ACO ID: A5045), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 249 traditional Medicare patients, billed 846 HCPCS/CPT codes, and received $57,494 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,397 prescription claims across 215 beneficiaries totaling $527,317 in drug costs, led by Breo Ellipta (Fluticasone/Vilanterol). DME data shows 460 claims. Open Payments data shows 1 records totaling $31. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $191,919 and ending at $527,317. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $20,322 and ending at $19,293.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	230	794	$60,131
2016	205	1,058	$58,596
2017	229	1,217	$67,926
2018	224	1,371	$67,020
2019	190	998	$54,056
2020	181	769	$65,875
2021	163	837	$46,645
2022	173	1,050	$39,481
2023	238	1,107	$58,757
2024	249	846	$57,494

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	170	798	$191,919
2016	165	892	$292,787
2017	177	926	$412,319
2018	169	846	$270,312
2019	144	849	$366,966
2020	129	818	$295,320
2021	145	846	$323,983
2022	147	890	$286,053
2023	151	915	$375,198
2024	215	1,397	$527,317

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	289	$10,907
2016	47	368	$21,084
2017	53	428	$12,310
2018	43	441	$14,996
2019	33	439	$15,598
2020	55	371	$14,189
2021	12	245	$9,609
2022	12	261	$11,992
2023	36	363	$17,173
2024	55	460	$19,112

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	61	159	$167
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	63	91	$70
94729	Test to examine how well the lungs exchange gases	75	78	$42
94727	Test to determine lung volumes using gas dilution or washout	73	76	$32
94060	Test to measure expiratory airflow and volume changes before and after medication administration	58	60	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Breo Ellipta	Fluticasone/Vilanterol	262	11,760	$148,851
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	75	2,940	$60,251
Nucala	Mepolizumab	14	392	$52,290
Xolair	Omalizumab	13	364	$48,399
Dupixent Pen	Dupilumab	12	336	$44,904

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	11	81	$5,573
A7031	Face mask interface, replacement for full face mask, each	N	N/R	26	$2,231
A7030	Full face mask used with positive airway pressure device, each	N	N/R	26	$1,999
E0601	Continuous positive airway pressure (cpap) device	Y	12	61	$1,926
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	26	$1,656

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$31	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aalok Devendra Shah, M.D.?

Tedicare shows public-source Medicare data for Aalok Devendra Shah, M.D. (NPI 1568429678), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aalok Devendra Shah, M.D. have ACO affiliation data?

Aalok Devendra Shah, M.D. is shown with ACO affiliation data for Optum California ACO (MSSP, ACO ID A5045).

What billing organization is linked to Aalok Devendra Shah, M.D.?

Aalok Devendra Shah, M.D. is linked to DARIN RENTZ DO PC (billing NPI 1689321747) in the available physician profile data.

Does Aalok Devendra Shah, M.D. have Open Payments data?

Aalok Devendra Shah, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.